Dose escalation with over-dose and under-dose controls in Phase I/II clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dose escalation with over-dose and under-dose controls in Phase I/II clinical trials

Published:2015-07 Issue: Volume:43 Page:133-141
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Chen Zhengjia,Yuan Ying,Li Zheng,Kutner Michael,Owonikoko Taofeek,Curran Walter J.,Khuri Fadlo,Kowalski Jeanne

Funder

NIH/NCI

Leukemia & Lymphoma Society Translational Research Program Award

Phase I Program of Winship Cancer Institute of Emory University

Winship Cancer Institute of Emory University

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference23 articles.

1. Cancer phase I clinical trials: efficient dose escalation with overdose control;Babb;Stat. Med.,1998

2. Continual reassessment method: a practical design for phase 1 clinical trials in cancer;O'Quigley;Biometrics,1990

3. Patient specific dosing in a cancer phase I clinical trial;Babb;Stat. Med.,2001

4. Unifying CRM and EWOC designs for phase I cancer clinical trials;Chu;J. Stat. Plan. Inference,2009

5. A novel toxicity scoring system treating toxicity response as a quasi-continuous variable in Phase I clinical trials;Chen;Contemp. Clin. Trials,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bayesian dose escalation with overdose and underdose control utilizing all toxicities in Phase I/II clinical trials;Biometrical Journal;2023-12-04

2. Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study;BMC Medicine;2023-07-05

3. Combining Cytotoxic Agents with Continuous Dose Levels in Seamless Phase I-II Clinical Trials;Journal of the Royal Statistical Society Series C: Applied Statistics;2022-10-26

4. Dose Finding for Drug Combinations;Principles and Practice of Clinical Trials;2022

5. Designs of Early Phase Cancer Trials with Drug Combinations;Emerging Topics in Statistics and Biostatistics;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3